Doxorubicin Recruiting Phase 2 Trials for Chemotherapeutic Toxicity / Quality of Life / Abdominal wall neoplasm / Peritoneum; Carcinomatosis / Histologic Progression / Chemotherapy Effect / Metastases to peritoneum Treatment